We found that the marrow levels of VEGF/PlGF, Ang-2, and Tie-2 were significantly higher (P<0.001) and those of VEGF-C and Ang-1 were significantly lower (P<0.001) in the AML patients as compared to those values in healthy controls. This evidence concerns the gene VEGFA and acute myeloid leukemia.